CCTA offers clinicians an opportunity to make patient care more efficient. However, interventionalists need to make sure they understand how to properly interpret coronary CT data.

The Freesolve Resorbable Magnesium Scaffold previously received the same designation for below-the-knee interventions. This update covers minimally invasive coronary procedures.

The upcoming Society of Thoracic Surgeons annual meeting in San Diego is scheduled to feature multiple big-name speakers. The four-day event runs Jan. 28-31, 2027. 

These findings call into question the types of screenings firefighters should undergo to detect potential heart problems.

Researchers tracked years of real-world data, noting that the mortality rates for TAVR and SAVR were comparable once patients were discharged.

Cardiac arrest still occurs during nearly 1% of all PCI procedures. It is most common during acute coronary syndrome interventions.

According to Elucid, the development of its FFR-IQ software was guided by clinician feedback.

Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially approved for both mitral valve repair and tricuspid valve repair.

Some parents may be unsure about giving their children these medications. However, it can be worth it to avoid a lifetime of high blood pressure and other potentially harmful health conditions.

Children with congenital heart disease outgrow their replacement valves, requiring repeat open-heart surgeries. The Autus can be expanded using a transcatheter procedure.

A new STEMI medication from CeleCor Therapeutics is now one step closer to a potential FDA approval.

The deal to buy Integris was signed Wednesday. Once finalized, the health system will join Risant Health, a Kaiser subsidiary. The financial terms were not revealed.

University of Pittsburgh experts believe the model could help radiologists identify cases when an AI-generated result may need a second look.